These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 7488443)

  • 1. Angiographic trials of lipid-lowering therapy: end of an era?
    Thompson GR
    Br Heart J; 1995 Oct; 74(4):343-7. PubMed ID: 7488443
    [No Abstract]   [Full Text] [Related]  

  • 2. Lipids and prevention in coronary care.
    Betteridge DJ
    Trans Med Soc Lond; 1994-1995; 111():43-58. PubMed ID: 9156156
    [No Abstract]   [Full Text] [Related]  

  • 3. Implications of 4S evidence on baseline lipid levels.
    Durrington PN
    Lancet; 1995 Jul; 346(8968):181. PubMed ID: 7661979
    [No Abstract]   [Full Text] [Related]  

  • 4. Implications of 4S evidence on baseline lipid levels.
    Ravnskov U
    Lancet; 1995 Jul; 346(8968):181. PubMed ID: 7603244
    [No Abstract]   [Full Text] [Related]  

  • 5. Implications of 4S evidence on baseline lipid levels.
    Jacobson TA
    Lancet; 1995 Jul; 346(8968):181-2. PubMed ID: 7603245
    [No Abstract]   [Full Text] [Related]  

  • 6. Profiling a landmark clinical trial: Scandinavian Simvastatin Survival Study.
    Guptha S
    Curr Opin Lipidol; 1995 Oct; 6(5):251-3. PubMed ID: 8520845
    [No Abstract]   [Full Text] [Related]  

  • 7. The Scandinavian Simvastatin Survival Study (4S) subgroup analysis of diabetic subjects: implications for the prevention of coronary heart disease.
    Haffner SM
    Diabetes Care; 1997 Apr; 20(4):469-71. PubMed ID: 9096961
    [No Abstract]   [Full Text] [Related]  

  • 8. [The 4-S study--a turning point in the cholesterol debate. Work Group Lipids and Atherosclerosis of the Swiss Society for Cardiology].
    Nigg C
    Praxis (Bern 1994); 1995 Dec; 84(51-52):1514-6. PubMed ID: 8571010
    [No Abstract]   [Full Text] [Related]  

  • 9. Cholesterol-lowering therapy after heart transplantation: a 12-month randomized trial.
    Pflugfelder PW; Huff M; Oskalns R; Rudas L; Kostuk WJ
    J Heart Lung Transplant; 1995; 14(4):613-22. PubMed ID: 7578166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The 4S study: a critical review.
    Pauciullo P
    Pharmacol Res; 1997 Mar; 35(3):165-6. PubMed ID: 9229401
    [No Abstract]   [Full Text] [Related]  

  • 11. Primary prevention of cardiovascular disease: implications of lipid-lowering trials.
    Pedersen TR
    J Hypertens Suppl; 1996 Dec; 14(5):S195-200. PubMed ID: 9120679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selection of appropriate type and intensity of lipid-lowering therapy.
    Tikkanen MJ
    Curr Opin Lipidol; 1995 Dec; 6(6):360-4. PubMed ID: 8750248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The statin trials: closing arguments in the case against cholesterol?
    Gaw A
    Scott Med J; 1996 Aug; 41(4):99-100. PubMed ID: 8873306
    [No Abstract]   [Full Text] [Related]  

  • 14. Treating hypercholesterolemia aggressively.
    Wilson CS
    Nebr Med J; 1996 Jan; 81(1):3-4. PubMed ID: 8584066
    [No Abstract]   [Full Text] [Related]  

  • 15. Drug treatment of hypercholesterolaemia in a patient with Gilbert's syndrome.
    Cummings MH; Watts GF
    Ann Clin Biochem; 1994 Jul; 31 ( Pt 4)():383-5. PubMed ID: 7979108
    [No Abstract]   [Full Text] [Related]  

  • 16. Simvastatin in the secondary prevention of coronary heart disease.
    Assmann G
    Pharmacol Res; 1997 Mar; 35(3):161. PubMed ID: 9229399
    [No Abstract]   [Full Text] [Related]  

  • 17. Cost-benefit analysis of lipid lowering therapy.
    Davie AP; McMurray JJ
    Eur Heart J; 1996 Jul; 17(7):974-5. PubMed ID: 8809507
    [No Abstract]   [Full Text] [Related]  

  • 18. Scandinavian simvastatin study (4S).
    Grodos D; Tonglet R
    Lancet; 1994 Dec 24-31; 344(8939-8940):1768. PubMed ID: 7997017
    [No Abstract]   [Full Text] [Related]  

  • 19. Statins: is there a need for alternative or adjunctive therapy?
    Shepherd J
    Br Heart J; 1995 Jul; 74(1):13. PubMed ID: 7662445
    [No Abstract]   [Full Text] [Related]  

  • 20. What is the role of lipid lowering therapy in heart-allograft failure?
    Reichart B; Meiser BM; Wenke K; Brandl U; Seidel D; Thiery J
    Kidney Int Suppl; 1995 Dec; 52():S52-5. PubMed ID: 8587284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.